A perspective on molecular therapy in cholangiocarcinoma: present status and future directions. - Wikidata - wikimedia - TriplyDB

A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.

A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.

http://www.wikidata.org/entity/Q37719383

about

Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.Dual-modality imaging demonstrates the enhanced antitumoral effect of herpes simplex virus-thymidine kinase/ganciclovir plus gemcitabine combination therapy on cholangiocarcinoma.LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours Multimodal treatment strategies for advanced hilar cholangiocarcinoma.Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure.High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.Current Progress in Immunotherapy for the Treatment of Biliary Cancers.Biliary cancer: Utility of next-generation sequencing for clinical management.The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma.

P2860

Q35913384-C35F3EBB-E7F7-4B5B-8A16-82B60D3EA43B Q37001522-0BF4816E-1B53-4FE1-9E91-35F752016F5C Q37282535-0845D28B-0203-4540-A91E-A10099DE3523 Q38222988-88724C79-2A49-41AA-BEA4-94F3731E330A Q38577917-3A894C02-814C-4783-AAA0-434E9B1312E1 Q38807021-9F74350B-8E2D-47FA-A19D-DA339C323A08 Q38830071-3C63A3A0-526B-44BD-B0B3-725D032D9EA6 Q39396785-836BE7CC-245C-411C-98E4-1A9EB3BA26CE Q42140819-5E2F15F8-2B2C-4F41-A76E-184E5CDE557E

P2860

A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.

http://www.wikidata.org/entity/Q37719383

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A perspective on molecular the ...... status and future directions.

@en

A perspective on molecular the ...... status and future directions.

@nl

type

label

A perspective on molecular the ...... status and future directions.

@en

A perspective on molecular the ...... status and future directions.

@nl

prefLabel

A perspective on molecular the ...... status and future directions.

@en

A perspective on molecular the ...... status and future directions.

@nl

P1433

Q37719383-C0640367-96BE-4C9F-9BBC-23E26AE5E318

P1476

Q37719383-09E4EC36-6996-4E2A-AAE6-899D43D2EE76

P2093

Q37719383-12B34CFC-4B07-4D38-9F4F-7B2B32BCB087

P2860

Q37719383-014FA455-481F-4382-8B7E-51D76994B97F

Q37719383-023C8531-955C-4A9D-BDDE-138112A910A4

Q37719383-07ED7F29-2B5B-4574-9148-2CD8CE3D2E3D

Q37719383-0E5E5550-2C80-4658-9E31-6B4CC22850E9

Q37719383-139A1D2E-ACDF-46F0-8CDD-C36F9A6B5B77

Q37719383-1612425F-93DF-41C7-ACEE-241FA80A0089

Q37719383-167C32DC-8A9E-4DE0-A1DB-0023D5D4249F

Q37719383-1716F51B-804A-4FA9-BC84-C3F4B0C8ABBD

Q37719383-19FCE1A9-F14A-4913-B44E-96D6294F9D9B

Q37719383-1E5785B7-878F-4225-9F1B-5ABB374FB359

P304

Q37719383-EDBE5A37-E62C-4EB0-9CD8-9952D7892F78

P31

Q37719383-89AFC8C4-C44C-43A9-A8FB-3268A9E4DC17

P356

Q37719383-1837DC5A-B59D-4883-92FB-2BBF26A3B865

P433

Q37719383-F9BDC9A8-1FB8-48ED-876A-55C534FED3F8

P478

Q37719383-5AEBD228-6117-4D3D-B7C8-26F2657E6B41

P50

Q37719383-18B82E5A-403E-4DC5-81F4-FEA95E3B387C

P577

Q37719383-D06C2608-0A4A-4D28-A7BE-3FFD8FC939B1

P5875

Q37719383-675EE8CF-A1AA-4425-A7AA-A368AE41ECB3

P698

Q37719383-3487ADFF-D8F7-4862-946D-BA6A454945B8

P921

Q37719383-C66B15F2-0BF5-4675-91DD-E2A877103DCB

P932

Q37719383-6AA0A98C-4646-460D-ACBE-6BC7CD8F718B

P356

P1433

Hepatic oncology

P1476

A perspective on molecular the ...... t status and future directions

@en

P2093

Snorri S Thorgeirsson

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas

Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends

Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies

Genetic profiling of intrahepatic cholangiocarcinoma

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours

Classification, diagnosis, and management of cholangiocarcinoma

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report.

P304

143-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/HEP.13.4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Jesper B. Andersen

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261923363

http://www.w3.org/2001/XMLSchema#string

P698

24772266

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

3997260

http://www.w3.org/2001/XMLSchema#string